HMGB1 and neoplasm: Consistently, RA‐biotin‐captured TDP‐43 (Figure 5F) and RA‐induced HMGB1‐Gluc activity (Figure S6D, Supporting Information) were dramatically reduced in CRISPR‐Cas9‐engineered TDP‐43KO tumor cells.